Correlation Between Amphastar and Citius Oncology,
Can any of the company-specific risk be diversified away by investing in both Amphastar and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amphastar and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amphastar P and Citius Oncology,, you can compare the effects of market volatilities on Amphastar and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amphastar with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amphastar and Citius Oncology,.
Diversification Opportunities for Amphastar and Citius Oncology,
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Amphastar and Citius is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Amphastar P and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and Amphastar is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amphastar P are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of Amphastar i.e., Amphastar and Citius Oncology, go up and down completely randomly.
Pair Corralation between Amphastar and Citius Oncology,
Given the investment horizon of 90 days Amphastar P is expected to generate 0.21 times more return on investment than Citius Oncology,. However, Amphastar P is 4.83 times less risky than Citius Oncology,. It trades about 0.03 of its potential returns per unit of risk. Citius Oncology, is currently generating about -0.2 per unit of risk. If you would invest 4,225 in Amphastar P on September 1, 2024 and sell it today you would earn a total of 294.00 from holding Amphastar P or generate 6.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 61.9% |
| Values | Daily Returns |
Amphastar P vs. Citius Oncology,
Performance |
| Timeline |
| Amphastar P |
| Citius Oncology, |
Amphastar and Citius Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Amphastar and Citius Oncology,
The main advantage of trading using opposite Amphastar and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amphastar position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.| Amphastar vs. Collegium Pharmaceutical | Amphastar vs. Alkermes Plc | Amphastar vs. Evolus Inc | Amphastar vs. Neurocrine Biosciences |
| Citius Oncology, vs. Verve Therapeutics | Citius Oncology, vs. Beam Therapeutics | Citius Oncology, vs. Caribou Biosciences | Citius Oncology, vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |